Glimepiride
Glimepiride is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: Glimepiride; Generic name: GLIMEPIRIDE; Drug class: Sulfonylurea [EPC].
| Brand name | Glimepiride |
|---|---|
| Generic name | GLIMEPIRIDE |
| Drug class | Sulfonylurea [EPC] |
| Manufacturer | Dr. Reddy's Laboratories Limited |
| Used for | 1 INDICATIONS AND USAGE Glimepiride tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus [see Clinical Studies ( 14.1 ) ]. Limitations of Use Glimepiride tablets should not be used for the treatment of type 1 diabetes mellitus or diabetic ketoacidosis, as it would not be effective in these settings. Glimepiride tablets are a sulfonylurea indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus ( 1 ). Limitations of Use : Not for treating type 1 diabetes mellitus or diabetic ketoacidosis ( 1 ). |
| Dosage | 2 DOSAGE AND ADMINISTRATION Recommended starting dose is 1 or 2 mg once daily. Increase in 1 or 2 mg increments no more frequently than every 1 to 2 weeks based on glycemic response. Maximum recommended dose is 8 mg once daily. ( 2.1 ) Administer with breakfast or first meal of the day. ( 2.1 ) Use 1 mg starting dose and titrate slowly in patients at increased risk for hypoglycemia (e.g., elderly, patients with renal impairment). ( 2.1 ) 2.1 Recommended Dosing Glimepiride tablets should be admin |
| Active ingredient(s) | GLIMEPIRIDE |
| Route | ORAL |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=07ad4366-4b21-f633-49f3-c2b35f88168d |